Key PointsAdjusted earnings per share of $1.77 topped analyst expectations in Q2 2025 and GAAP revenue was $44.4 billion, beating…
Key PointsNon-GAAP earnings per share of $1.66 in Q2 2025 exceeded analyst estimates by 4.4%.GAAP revenue rose 6% to $966…
Key PointsNon-GAAP loss per share widened to ($0.15) versus estimates of ($0.13), reflecting soft demand and margin compression.Positive movement seen…
Key PointsNon-GAAP EPS of $0.55 beat estimates by $0.01 in Q2 2025; GAAP revenue of $642 million in Q2 2025…
Key PointsGAAP earnings per share for Q2 2025 showed a wider loss than last year, but still exceeded analyst forecasts.Revenue…
Key PointsEarnings per share (GAAP) and revenue (GAAP) both increased sharply year over year but missed analyst estimates (GAAP) for…
Key PointsRevenue (GAAP) fell to $209.6 million in the quarter, missing the $220.6 million estimate and declining 4.8% year over…
Key PointsRecord GAAP revenue for Q2 2025 reached $784.0 million, surpassing estimates and up 42.3% versus the prior year.Earnings per…
Key PointsNet loss (GAAP) widened sharply due to increased spending in Q2 2025, with GAAP EPS was ($0.46) for Q2…
Key PointsGAAP earnings per share for Q2 2025 were $3.78, surpassing estimates of $3.57 and Earnings per share reached $3.78,…
Key PointsNon-GAAP earnings per share reached $0.51 for Q2 2025, beating the analyst estimate of $0.25 (non-GAAP).Revenue (GAAP) grew to…
Key PointsNon-GAAP earnings per share surpassed expectations at $1.49, outpacing the consensus non-GAAP EPS estimate of $1.42.Revenue (GAAP) came in…
Key PointsGAAP earnings per share of $1.76 for Q2 2025 exceeded analyst estimates by 10.0%, Earnings per share of $1.76…
Key PointsAdjusted earnings per share rose 10% to $4.43, beating expectations for Q2 2025.Revenue grew 6% to $3.76 billion (GAAP)…
Key PointsRevenue (GAAP) surpassed consensus estimates by approximately 3.7%, rising 5% to $524.2 million, driven by increased student enrollments.Adjusted earnings…
Key PointsNon-GAAP core earnings per share were $0.31, missing analyst estimates by 3.1% and remaining flat from the prior year.GAAP…
Key PointsAdjusted net sales reached $801.4 million in Q2 2025, topping analyst estimates on a non-GAAP basis and prior guidance.Gross…
Key PointsRevenue (GAAP) for Q2 2025 reached $1,586 million, topping GAAP expectations by $76.0 million and up 8.2% compared to…
Key PointsGAAP revenue reached a record $293.3 million in Q1 FY2026, but missed analyst estimates by 3%.Earnings per share were…
Key PointsRevenue (GAAP) reached $124.1 million, surpassing the $115.5 million GAAP estimate and rising 29.7% year-over-year.Non-GAAP earnings per share improved…
Key PointsEarnings per share (Non-GAAP) rose to $0.52, beating the analyst estimate by 13.0 %.Revenue (GAAP) grew 8.4% to $1,034.9…
Key PointsRevenue rose 16.6% in Q1 fiscal 2026, but missed analyst expectations by 17.5% (GAAP).Adjusted earnings per share (Non-GAAP) grew…
Key PointsEPS beat estimates, with a GAAP loss per share of $0.41 compared to the expected $0.43 in Q2 2025.Phase…
Key PointsRobinhood Markets (NASDAQ:HOOD) reported GAAP earnings and revenue for Q2 2025 well ahead of analyst expectations, driven by strong…
Key PointsRevenue (GAAP) rose 15% year-over-year in Q2 2025, easily surpassing expectations and driven by strong U.S. and international growth.Gross…
Key PointsNon-GAAP earnings per share of $1.65 for Q2 2025 vastly exceeded the analyst estimate of $0.96.GAAP revenue reached $687.5…
Key PointsIntegra LifeSciences (NASDAQ:IART) delivered GAAP revenue of $415.6 million in Q2 2025, beating analyst estimates by $20.6 million (GAAP)…
Key PointsEarnings per share (non-GAAP) missed estimates at $0.66, down from $0.81 (non-GAAP) in Q2 2024.Below analyst expectations, with non-GAAP…
Key PointsEarnings per share (Non-GAAP) surpassed estimates at $1.64, up 10.1% year-over-year.Revenue (GAAP) reached $972.4 million, exceeding GAAP expectations by…
Key PointsRevenue (GAAP) surged 21% to $730.6 million, beating estimates by $62.1 million.Non-GAAP EPS set a quarterly record at $0.58,…
Key PointsGAAP revenue of $342.3 million for Q2 2025 exceeded analyst estimates and This figure represented a 3.1% increase compared…
Key PointsRevenue (GAAP) surpassed expectations at $249 million for Q2 2025, marking a 4% year-over-year increase.Non-GAAP earnings per share reached…
Key PointsImpinj (NASDAQ:PI) reported Q2 2025 revenue of $97.9 million and non-GAAP EPS of $0.80, both surpassing analyst estimates. despite…
Key Points- Non-GAAP earnings per share beat estimates at $1.29, up 12.2% year-over-year.- Revenue (GAAP) of $4.14 billion missed consensus…
Key PointsAdjusted earnings per share for Q2 2025 reached $6.27, falling short of analyst expectations and only slightly up from…
Key PointsGAAP earnings per share of $1.03 in Q2 2025 exceeded analyst expectations by 43.1%.GAAP revenue rose 10.1% year-over-year to…
Key PointsEPR Properties (NYSE:EPR) posted GAAP revenue of $178.1 million in Q2 2025, beating analyst estimates by 23.6%.Funds From Operations…
Key PointsRevenue (GAAP) rose 20.9% to $511.5 million in Q2 2025, beating analyst estimates by $50.5 million.GAAP diluted EPS was…
Key PointsGAAP revenue for Q2 2025 exceeded expectations at $4.40 billion, Revenue reached $4.40 billion, a 2% increase over the…
Key PointsRevenue (GAAP) rose 4% to $869.5 million for Q4 FY2025, beating analyst expectations by $25.26 million.The quarter ended with…
Key PointsEarnings per share (non-GAAP) beat expectations at $1.65, compared to the $1.36 estimate for Q2 2025.Revenue (GAAP) rose 6%…
Key PointsAdjusted EPS (Non-GAAP) of $1.37 in Q2 2025 beat analyst expectations by 18.6%, though it dipped 3.5% from the…
Key PointsGAAP EPS of $0.23 surpassed expectations by $0.06 in Q2 2025 andGAAP revenue of $72.8 million beat estimates in…
Key PointsNon-GAAP earnings per share for Q2 FY2025 was ($2.88), This missed estimates by $5.06. and This compares to ($1.93)…
Key PointsEarnings and revenue for Q2 2025 both fell short of expectations, with non-GAAP EPS of $2.49, compared to the…
Key PointsIonis Pharmaceuticals (NASDAQ:IONS) reported Q2 2025 GAAP revenue and non-GAAP earnings per share that exceeded analyst expectations by wide…
Key PointsGAAP revenue of $1.67 billion in Q1 FY2026 topped estimates by $0.18 billion and exceeded management’s guidance midpoint by…
Key PointsLam Research reported non-GAAP revenue and profits that far exceeded analyst expectations for Q2 FY2025. Revenue increased 33.6% year…
Key PointsGAAP revenue rose 20% year over year to $282.3 million in Q2 2025, surpassing consensus GAAP revenue estimates by…
Key PointsRevenue (GAAP) surged 79.7% year over year to $72.4 million, exceeding the $64.9 million consensus estimate.Non-GAAP EPS rose to…